This site is intended for Healthcare Professionals only.

Susan Rienow to take up ABPI President role in May

Date:

Share post:

The Association of the British Pharmaceutical Industry (ABPI) has appointed Susan Rienow, UK Country President of Pfizer as its next President.

Susan was appointed as ABPI Vice-President in September 2022 and will formally take up her role as President in May 2023.

The association confirmed that Susan will lead the ABPI Board as President to deliver the organisation’s mission to make the UK the best place in the world to research, develop and use new medicines and vaccines.

At Pfizer, Susan leads the organisation across the breadth of Pfizer’s innovative medicines and vaccines portfolio. She previously led Pfizer UK’s Vaccines business unit during the COVID-19 pandemic.

Commenting on her appointment, Susan said: “I’m delighted to be taking up the role of ABPI President at such a huge moment of opportunity for both the UK and our industry.

“The Government has set out a bold ambition to be a science superpower, and with a new Department for Science, Innovation and Technology, I believe that the industry and Government can drive this agenda together to deliver long term economic growth.

“Our industry is developing a new generation of medicines and vaccines, and I look forward to working with colleagues across the industry, Government and the NHS to ensure these can help transform the lives of people across the country”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Over half a million dementia cases could go undiagnosed by 2040, study predicts

Currently, an estimated 850,000 people are living with dementia in the UK, with 315,000 undiagnosed cases As the...

GPhC explores potential benefits of covert surveillance powers

GPhc to address ethical concerns regarding covert surveillance, particularly in online pharmacy probes  In a recent minute of meeting,...

UKPPLAB to elevate pharmacist satisfaction and enhance patient safety

PDA advocates pharmacist autonomy in professional leadership amid CPhO influence In a bid to bolster professional leadership within the...

Former NPA director Phil Galt named new Cegedim Rx UK managing director

Phill Galt replaces Adam Dennett who stepped down from the Cegedim Rx's leadership role after a successful ten-year...